Peters, Stabenow Announce $315 Million in Federal Funding to Expand COVID-19 Testing in Michigan

Senators Pushed to Include Funding for Testing in Paycheck Protection Program and Health Care Enhancement Act

WASHINGTON, DC – U.S. Senators Gary Peters (MI) and Debbie Stabenow (MI) today announced $315 million in federal funds will be awarded to the State of Michigan to expand its coronavirus testing operations. This funding comes from the $25 billion for testing that Peters and Stabenow fought to be included as part of the Paycheck Protection Program and Health Care Enhancement Act they helped enact last month.

“We know that dramatically expanding testing capabilities is a necessary step towards reopening the economy in Michigan and across the country. That’s why Senator Stabenow and I fought to ensure the final bill was heavily improved to include funding for testing,” said Senator Peters, Ranking Member of the Senate Homeland Security and Governmental Affairs Committee. “This will help prevent the spread of this devastating virus so workers, families and small businesses can all work toward a new normal in a safe and healthy way. Ultimately, however, we still have not seen a thorough plan to ramp up widespread testing on the federal level, and I urge the Trump Administration to work with Congress on ways to prioritize increased testing moving forward.”

“Widespread testing is absolutely critical to keeping us and our loved ones safe as we reopen our economy,” said Senator Stabenow. “I fought for this funding in the last COVID-19 bill so that Michigan could expand its testing capabilities. This is a good start but the Administration must provide more funding so that our state can safely reopen its economy, get people back to work, and limit the spread of COVID-19.”

The $25 billion Peters and Stabenow secured in the Paycheck Protection Program and Health Care Enhancement Act includes $11 billion going to federal testing funds for individual states and $14 billion going to federal agencies including the U.S. Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). This funding will support research, development and deployment of tests.